Methadone linked to deaths, life-threatening effects, say FDA News item 09 February 2013 Pages: 2 - 2
Risk management plans – one year on from the EMEA guidelines R Stather Meeting report 09 February 2013 Pages: 3 - 4
Calcium acetate does not appear to increase the risk of cardiovascular calcinosis over sevelamer Media release 09 February 2013 Pages: 4 - 4
Cardiovascular/cerebrovascular risks with naproxen, celecoxib? Clinical study 09 February 2013 Pages: 5 - 5
The risks to the prostate of testosterone replacement therapy for late-onset hypogonadism “may not be as great as once believed” Clinical study 09 February 2013 Pages: 5 - 5
Moxifloxacin prophylaxis is associated with higher bacteraemia and adverse event rates than levofloxacin prophylaxis Clinical study 09 February 2013 Pages: 5 - 5
Warfarin recipients who start gatifloxacin may have a higher risk of an INR > 4 than those who start levofloxacin Clinical study 09 February 2013 Pages: 5 - 5
EGb 761, a Ginkgo biloba extract, affects the pharmacology of tolbutamide and midazolam Volunteers 09 February 2013 Pages: 5 - 5
